EIF3B and head and neck squamous cell carcinoma: This study reveals EIF3B as a novel oncogene in HNSCC that promotes transcription factor CEBPB translation and subsequent IL6R expression, and these findings provide a link between the molecular basis and pathogenesis of HNSCC.